ROME Therapeutics is a biotechnology company focused on developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome, which are vast stretches of uncharted genomic sequences. The company aims to illuminate the dark genome to pioneer new approaches to treating serious diseases.
Focus Areas
Notable Investments
